News | May 13, 2013

New Era in Pediatric Interventional Cardiology Training Needed

Frank Ing spotlights need for new training initiatives to meet challenges, opportunities of the future during SCAI

May 13, 2013 — The impact of pediatric interventional cardiology has never been stronger, nor the need for organized, high-quality training greater, says Frank F. Ing, M.D., FSCAI, who delivered the annual Mullins Lecture at the Society for Cardiovascular Angiography and Interventions (SCAI) 2013 Scientific Sessions. He made the case that advances in technology and growth in the profession mean that now is the time to take training to the next level.

“We’re experiencing a golden era in pediatric interventions,” said Ing, the associate chief of cardiology and director of the cardiac catheterization laboratory at Children’s Hospital Los Angeles. “We’re crossing a threshold that establishes this as a legitimate field that will have a huge impact on pediatric cardiology. As such, we need to start thinking more about how we train the people doing these procedures, to maintain quality and to maintain a movement going forward.”

In his keynote address, Ing focused on the past, present and future of training in pediatric interventional cardiology. Afterward, he co-moderated a panel discussion on fellowship training.

The issue of training in pediatric interventional cardiology is becoming increasingly important these days. Not only have multiple pediatric interventional devices been approved by the U.S. Food and Drug Administration (FDA), but pediatric cardiologists increasingly collaborate with interventionalists specializing in adult structural heart disease and perform hybrid procedures with congenital heart surgeons.

The Mullins Lecture, and the panel discussion afterward, explored the need for guidelines on fellowship training in pediatric interventional cardiology. Scheduled to be published soon, the guidelines are expected to include recommendations on the scope of fellowship training and the minimum number of cases needed to develop expertise in specific pediatric interventional procedures.

“To move forward, you have to maintain a legacy of teaching, of impacting the next generation and their careers and of adding to the science of the field,” he said. “We’ve done it all along, but in a random fashion. Now we have enough critical mass to think hard about organizing official guidelines and some common techniques to training, perhaps using SCAI as a sponsoring umbrella organization.”

 For more information:

Related Content

Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Recent Acquisitions Eroding Prices in Billion Dollar European Interventional Cardiology cath lab Market.
Feature | Cath Lab | May 07, 2018 | Simon Trinh and Jeffrey Wong
The European interventional cardiology market is currently valued at nearly $1.4 billion.
Videos | Cath Lab | May 07, 2018
Imran Ahmad, M.D., medical director of interventional cardiology, explains some of the new technologies his labs have
360 Photos | Cath Lab | April 20, 2018
A 360 degree view of the newest cath lab at Northwestern Medicine Central DuPage Hospital in Winfield, Ill., located
SCAI Announces Global Lecture Series for 2018 Scientific Sessions
News | Cath Lab | April 18, 2018
Many of the world’s leading interventional cardiologists and cardiovascular professionals will convene in San Diego,...
Overlay Init